Panacea Biotec Ltd

NSE :PANACEABIO   BSE :531349  Sector : Pharmaceuticals
Buy, Sell or Hold PANACEABIO? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

18 Nov
375.55
(4.99%)
14 Nov
357.70
(4.99%)
13 Nov
340.70
(1.55%)
12 Nov
335.50
(-4.09%)
11 Nov
349.80
(-2.15%)
08 Nov
357.50
(-4.30%)
07 Nov
373.55
(-5.00%)
06 Nov
393.20
(4.27%)
05 Nov
377.10
(5.00%)
04 Nov
359.15
(3.23%)
01 Nov
347.90
(4.96%)
31 Oct
331.45
(4.99%)
30 Oct
315.70
(3.97%)
29 Oct
303.65
(2.26%)
28 Oct
296.95
(4.98%)
25 Oct
282.85
(-3.17%)
24 Oct
292.10
(-4.93%)
23 Oct
307.25
(-0.89%)
22 Oct
310.00
(-5.00%)
21 Oct
326.30
(-4.99%)
18 Oct
343.45
(-2.36%)


Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bullish

353.51


10 DMA
Bullish

362.6


20 DMA
Bullish

336.76


50 DMA
Bullish

319.41


100 DMA
Bullish

241.15


200 DMA
Bullish

191.45



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 18, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 393.61 384.58 379.28 - -
R2 384.58 379.4 378.03 385.71 -
R1 380.06 376.21 376.79 382.32 382.33
P 371.03 371.03 371.03 372.16 372.16
S1 366.51 365.85 374.31 368.77 368.78
S2 357.48 362.66 373.07 358.61 -
S3 352.96 357.48 371.82 - -

Key Metrics

EPS

0

P/E

0

P/B

7.29

Dividend Yield

0%

Market Cap

2,300 Cr.

Face Value

1

Book Value

51.69

ROE

-4.07%

EBITDA Growth

13.42 Cr.

Debt/Equity

0.02

Shareholding Pattern

  72.87% Total Promoter Holding
0% Mutual Fund Holdings
0.37% FIIs
25.6% Non Institution
0% Insurance Companies
0% Custodians
1.16% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Panacea Biotec Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 149.02 158.96 150.01 122.26 154.77
PROFIT -10.88 -4.36 -4.66 -18.62 1.97
EPS -1.35 -0.37 -0.23 -2.59 0.77

Panacea Biotec Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 96.72 98.28 96.76 60.68 80.05
PROFIT 3.2 0.43 -1.37 -13.78 1.29
EPS 0.52 0.07 -0.22 -2.25 0.21

Profit & Loss (Figures in Rs. Crores)


Panacea Biotec Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 700.81 700.9 607.49 611.51 758.16 607.3 629.25 2397.38 579.9 603.14
PROFIT -105.96 -66.53 -62.36 -73.98 -288.05 -159.82 -147.66 -197 -94.64 -33.96
EPS 0 0 0 0 5.64 -29.1 -24.11 176.05 -5.51 -0.25

Panacea Biotec Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 680.86 700.6 601.1 271.48 400.59 217.15 350.07 309.02 260.36 366.72
PROFIT -65.1 -48.78 -34.74 -71.88 -276.22 -121.7 -17.7 -93.59 -92.84 3.5
EPS 0 0.13 0 0 3.98 -22.93 -2.36 -15.28 -14.29 0.58

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 12.1211.116.136.136.136.136.136.1322.4322.43
Reserves Total 814.27815.82848.86-256.47138.87334.63292.91339.91426.18448.76
Equity Share Warrants00003200000
Equity Application Money21.6521.6521.6521.6521.799.649.649.6400.1
Total Shareholders Funds848.04848.58876.64-228.69198.79350.4308.68355.68448.61471.29
Minority Interest-3.82-3.49-2.98-3-3.04-3.01-2.9510.541.083.42
Secured Loans 00.240.29759.5708.64604.57906.96959.871,058.161,059.43
Unsecured Loans 151533.8760.0333.5541.9333.7933.7130.2735.45
Total Debt1515.2434.16819.53742.19646.5940.75993.581,088.431,094.88
Other Liabilities50.0860.7974.74225.05129.4843.7530.83120.6462.3426.28
Total Liabilities909.3921.12982.56812.891,067.421,037.641,277.311,480.441,600.461,595.87
APPLICATION OF FUNDS :
Gross Block 1,326.511,330.831,317.481,261.621,274.641,392.91,605.841,600.071,620.291,633.48
Less: Accumulated Depreciation744.66730.88695.41652.92617.25587.34656.87598.7549.18489.18
Net Block581.85599.95622.07608.7657.39805.56948.971,001.371,071.111,144.3
Capital Work in Progress101.542.3217.2634.4224.0122.5139.9330.41160.95155.48
Investments 40.4313.495.070.075.585.337.287.288.7115.18
Inventories 177.94202.09212.72174.14147.6981.43334.21315.55305.24310.22
Sundry Debtors 57.4260.0981.6684.6868.5288.73136.01142.17141.6798.57
Cash and Bank Balance139.48225.99583.28135.7989.7523.4823.2414.1322.9352.4
Loans and Advances 69.9860.7367.9116.36377.31314.2564.8761.3176.0259.55
Total Current Assets444.82548.9945.56510.97683.27507.89558.32533.17545.86520.74
Current Liabilities 273.01292.97740.28351.27315.48323.97314.04299.8251.94327.91
Provisions 35.8236.736.0313.377.4113.926.958.811.516.21
Total Current Liabilities & Provisions308.83329.67776.32364.65322.89337.89320.99308.61253.45334.12
Net Current Assets135.99219.23169.24146.32360.38170237.33224.56292.41186.62
Deferred Tax Assets76.7279.89127.44120.28135.63167.22219.22246.784.0389.11
Deferred Tax Liability99.27100.26103.69120.13133.68147.43208.82228.2984.5389.59
Net Deferred Tax-22.55-20.3723.750.151.9519.7910.418.41-0.5-0.48
Other Assets72.0866.5145.1623.2318.1114.4533.4198.4167.7894.77
Total Assets909.3921.13982.55812.891,067.411,037.641,277.311,480.441,600.461,595.87
Contingent Liabilities369.39655.75368.17406.99366.93404.06378.64364.27353.54353.5
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 12.1211.116.136.136.136.1315.596.1322.4322.43
Reserves Total 301.36297.87387.32480.39832.82402.71372.33440.06517.6517.28
Equity Share Warrants00003200000
Equity Application Money21.6521.6521.6521.6521.799.649.649.6400
Total Shareholders Funds335.13330.63415.1508.17892.74418.48397.56455.83540.03539.71
Secured Loans 00.240.295.0512.44604.57906.96959.87962.38955.95
Unsecured Loans 118.8797.2383.8760.0354.884.1153.2762.6556.7158.81
Total Debt118.8797.4784.1665.0867.24688.68960.231,022.521,019.091,014.76
Other Liabilities25.8520.2115.8820.5217.9714.1729.4221.9714.5212.38
Total Liabilities479.85448.31515.14593.77977.951,121.331,387.211,500.321,573.641,566.85
APPLICATION OF FUNDS :
Gross Block 900.61908.57907.86893.02905.42813.951,542.551,536.971,518.161,532.12
Less : Accumulated Depreciation 477.58473.21453.83428.77406.14317.52651.62594.95530.58472.44
Net Block 423.03435.36454.03464.25499.28496.43890.93942.02987.581,059.68
Capital Work in Progress96.5427.850.8812.973.743.137.1627.6819.0116.98
Investments 0.270.270.270.272.552.54344.88344.88394.66394.66
Inventories 107.93116.1129.2587.0499.2342.51149.1140.6136.57140.9
Sundry Debtors 11.0812.2723.3235.2917.6925.2142.27175.8142.21100.43
Cash and Bank Balance29.4443.2542.6988.9660.617.8511.797.219.3242.37
Loans and Advances 34.7627.5253.5781.26436.8840.5550.580.0853.0131.47
Total Current Assets183.2199.14248.82292.55614.32916.1353.65403.7341.11315.17
Current Liabilities 219.02222.06217.84192.08157.44311.05279.5279.99232.42307.23
Provisions 29.9728.7428.864.443.19.666.791.451.375.15
Total Current Liabilities & Provisions248.98250.79246.7196.52160.54320.72286.29281.45233.79312.38
Net Current Assets-65.78-51.662.1296.03453.77595.3967.36122.25107.322.79
Deferred Tax Assets46.0246.0272.090135.13166.64203.13234.6384.0389.11
Deferred Tax Liability70.8270.8272.090133.68147.43181.14202.7684.0389.11
Net Deferred Tax-24.8-24.8001.4519.2121.9931.8700
Other Assets50.661.357.8320.2517.164.6524.8931.6165.0792.74
Total Assets479.86448.31515.13593.77977.951,121.331,387.211,500.311,573.641,566.85
Contingent Liabilities369.39655.75368.17406.99366.93404.06378.64364.27353.54353.5

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...1.48
Depreciation36.71
Interest (Net)-4.79
Dividend Received0.01
P/L on Sales of Assets4.56
P/L on Sales of Invest-3.37
Prov. and W/O (Net)-5.96
P/L in Forex0.13
Total Adjustments (PBT and Ext...-8.76
Operating Profit before Workin...-7.28
Trade and 0ther Receivables2.96
Inventories24.16
Loans and Advances-27.96
Total Adjustments (OP before W...9.69
Cash Generated from/(used in) ...2.41
Direct Taxes Paid-2.51
Total Adjustments(Cash Generat...-2.51
Cash Flow before Extraordinary...-0.1
Net Cash from Operating Activi...-0.1
Purchased of Fixed Assets-77.72
Sale of Fixed Assets6.68
Purchase of Investments-301.66
Sale of Investments278.09
Interest Received8.37
Inter Corporate Deposits142.05
Net Cash used in Investing Act...10.23
Of the Long Tem Borrowings-0.24
Interest Paid-2.57
Net Cash used in Financing Act...-2.81
Net Profit before Tax and Extr...4.21
Depreciation21.09
Interest (Net)-1.44
Dividend Received0.01
P/L on Sales of Assets0.45
Prov. and W/O (Net)10.08
P/L in Forex0.79
Total Adjustments (PBT and Ext...30.95
Operating Profit before Workin...35.16
Trade and 0ther Receivables1.28
Inventories8.17
Loans and Advances-7.95
Total Adjustments (OP before W...4
Cash Generated from/(used in) ...39.15
Direct Taxes Paid-1.88
Total Adjustments(Cash Generat...-1.88
Cash Flow before Extraordinary...37.27
Net Cash from Operating Activi...37.27
Purchased of Fixed Assets-75.03
Sale of Fixed Assets6.64
Interest Received3.72
Net Cash used in Investing Act...-51.01
Proceed from 0ther Long Term B...215.34
Of the Long Tem Borrowings-193.93
Interest Paid-8.59
Net Cash used in Financing Act...12.82

Company Details

Registered Office
AddressAmbala-Chandigarh Highway,
CityLalru
StatePunjab
Pin Code140501
Tel. No.91-1762-505900
Fax. No.
Emailcorporate@panaceabiotec.com; investorgrievances@pa
Internethttp://www.panaceabiotec.com
Registrars
AddressAmbala-Chandigarh Highway
CityLalru
StatePunjab
Pin Code140501
Tel. No.91-1762-505900
Fax. No.
Emailcorporate@panaceabiotec.com; investorgrievances@pa
Internethttp://www.panaceabiotec.com
Management
Name Designation
Rajesh JainChairman & Managing Director
Sandeep JainJoint Managing Director
R L NarasimhanNon-Exec. & Independent Dir.
N N KhamitkarNon-Exec. & Independent Dir.
K M LalNon-Exec. & Independent Dir.
Vinod GoelGroup CFO & Company Secretary
Manjula UpadhyayNon-Exec. & Independent Dir.
Mukul GuptaNon-Exec. & Independent Dir.
Ankesh JainWhole-time Director
BHUPINDER SINGHNon-Exec. & Independent Dir.
Narotam Kumar JunejaNon Executive Director
Rajesh JainAdditional Director